Moreover, the expected inverse relationship between adiponectin and clinical outcomes may be modified by differential retention of high-molecular weight forms of adiponectin in renal failure, the nutritional and inflammatory status, adiponectin gene polymorphisms, and combination of these factors [12]. The gene discussed is ADIPOQ; the disease is kidney failure.